ReviewHuman vaccines2011
Molecular Pharming: future targets and aspirations.
Review in Human vaccines, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Advancing the frontier of plant-based therapeutics: critical innovations in molecular farming and bioprocess Integration.Biotechnology letters · 2026Review
- Immunity and Protective Efficacy of a Plant-Based Tobacco Mosaic Virus-like Nanoparticle Vaccine against Influenza a Virus in Mice.Vaccines · 2024Article
- Transgenic Soybean for Production of Thermostable α-Amylase.Plants (Basel, Switzerland) · 2024Article
- Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection.Vaccines · 2023Article
- Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022.Cancer management and research · 2023Article
- Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products.PloS one · 2020Article
- New Hope for a "Cursed" Crop? Understanding Stakeholder Attitudes to Plant Molecular Farming With Modified Tobacco in Europe.Frontiers in plant science · 2020Article
- Stable Expression of Adalimumab in Nicotiana tabacum.Molecular biotechnology · 2018Article
- The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.The oncologist · 2018Review
- Exploiting virus-like particles as innovative vaccines against emerging viral infections.Journal of microbiology (Seoul, Korea) · 2017Review
- Plasma-Derived Polyreactive Secretory-Like IgA and IgM OpsonizingFrontiers in immunology · 2017Article
- Efficient genetic transformation and regeneration system from hairy root of Origanum vulgare.Physiology and molecular biology of plants : an international journal of functional plant biology · 2016Article
- Assessment of heat shock protein 70 induction by heat in alfalfa varieties and constitutive overexpression in transgenic plants.PloS one · 2015Article
- Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.The Journal of infectious diseases · 2014Article
- Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Human vaccines & immunotherapeutics · 2014Article
- How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?Plant molecular biology · 2013Review
- Combinatorial Analysis of Secretory Immunoglobulin A (sIgA) Expression in Plants.International journal of molecular sciences · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Molecular Pharming represents an unprecedented opportunity to manufacture affordable modern medicines and make these available at a global scale. The area of greatest potential is in the prevention of infectious diseases, particular in underdeveloped countries where access to medicines and vaccines has historically been limited. This is why, at St. George's, we focus on diseases such as HIV, TB and rabies, and aim to develop production strategies that are simple and potentially easy to transfer to developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.